Medicines List
Key Medicine List Properties (see medicines-list.xlsx for more details)
| Name | Mechanism | Indication | Adverse_effects |
| acetylcysteine | generation of glutathione | paracetamol poisoning | nausea |
| activated charcoal | adsorption of drugs in gut | increase drug elimination and reduce drug absorption | black stools |
| alendronic acid | bisphosphonate | osteoporosis, Paget's disease | oesophageal reactions, abdominal pain and distension |
| aluminium hydroxide | gastric acid suppresion | dyspepsia | constipation |
| amiloride | diuretic, sodium channel blocker | hypertension | hyperkalaemia |
| amiodarone | potassium channel blocker | anti-arrhythmic | pulmonary fibrosis; hypthyroidism; hyperthyroidism |
| amitriptyline | amine neurotransmitter uptake blocker; sodium channel blocker | anti-depressant | dry mouth; urinary retention |
| amphetamine | amine neurotransmitter release | (none) | hypertension; tachycardia |
| andexanet | binding to rivaroxaban or apixaban | rivaroxaban or apixaban overdose | none reported |
| arsenic | inhibition of pyruvate dehyrogenase | (none) | vomiting; encephalopathy; death |
| aspirin | reduces prostaglandin production by inhibiting cyclo-oxygenase | prevention of cardiovascular events | bleeding |
| atenolol | beta adrenoceptor antagonist | hypertension, angina, cardiac arrhthymias | Bronchospasm |
| atropine | muscarinic antagonist | (none) | dry mouth; urinary retention |
| benzylpenicillin | antibacterial | bacterial infections | hypersensitivity; anaemia; leucopenia; thrombocytopenia |
| benzylpiperazine (BZP) | amine neurotransmitter release | (none) | hypertension; tachycardia |
| bevacizumab | binds vascular endothelial growth factor | cancer | bleeding, hypertension |
| bleomycin | induces DNA breaks | cancer | pneumonitis |
| busulfan | DNA cross-linking | conditioning prior to bone marrow transplant | veno-occlusive disease |
| caffeine | adenosine receptor antagonist; phosphodiesterase inhibitor | respiratory stimulant | nausea; tachycardia,sleeplessness |
| carbamazepine | sodium channel blocker | seizures | CNS symptoms |
| carbon monoxide | binding to haemoglobin | (none) | death |
| chloroquine | inhibits the parasitic enzyme heme polymerase | malaria, rheumatoid arthritis, discoid lupus erythematosus | hepatitis, cardiomyopathy, hallucination |
| ciclosporin | calcineurin inhibitor | autoimmunity/transplantation | Too many to mention |
| cilazapril | angiotensin converting enzyme inhibitor | hypertension | dry cough, angiodema |
| cimetidine | histamine-2 receptor antagonist | gastric acid hypersecretion | diarrhoea; constipation |
| ciprofloxacin | gyrase inhibitor | bacterial infection | GI symptoms |
| cisplatin | DNA cross-linking of purine bases | testicular cancer; ovarian cancer | nausea & vomiting; bone marrow suppression; peripheral neuropathy |
| clonidine | alpha2-adrenoceptor agonist | hypertension | hypotension |
| clopidogrel | Irreversibly inhibits ADP binding to the P2Y12 receptor on platelets | prevention of thromboembolism after percutaneous coronary intervention | bleeding |
| codeine | metabolism in the liver to morphine which is a full opioid agonist | mild to moderate pain; diarrhoea; non-productive cough | respiratory depression, nausea and vomiting, constipation |
| cyanide | inhibition of cytochrome C oxidase | (none) | death |
| cyclophosphamide | DNA cross-linking of guanine | lymphoma | nausea & vomiting; bone marrow suppression; hair loss |
| debrisoquine | prevents release of noradrenaline | antihypertensive. No longer used. Used now for phenotyping CYP2D6 | |
| desferoxamine | iron chelating agent | iron overdose | nausea |
| dexamethasone | antiinflammatory corticosteroid | inflammation; autoimmunity | insomnia |
| dexmedetomidine | alpha2 agonist | sedation | bradycardia |
| diazepam | positive allosteric modulator at GABAa receptors | anxiety | drowsiness, sedation |
| diclofenac | cyclooxygenase (COX) inhibition | inflammation | gastrointestinal |
| digoxin | NaK-ATPase inhibitor | atrial fibrillation | nausea; cardiac arrythmias; visual disturbance |
| digoxin specific F(ab) | binding to digoxin | digoxin overdose | hypokalaemia |
| doxorubicin | topoisomerase inhibitor | cancer | myelosuppression, alopecia, GI symptoms |
| doxycycline | ribosomal protein synthesis inhibitor | bacterial infection | GI symptoms |
| edetate disodium calcium | lead, mercury, arsenic chelating agent | lead, mercury, arsenic poisoning | nausea |
| enalapril | angiotensin converting enzyme inhibitor | hypertension; heart failure | hypotension; dry cough |
| ergotamine | vasoconstrictor (alpha-adrenergic?) | migraine | nausea; gangrene |
| erythromycin | ribosomal protein synthesis inhibitor | bacterial infection | GI symptoms |
| erythromycin | macrolide antibacterial | bacterial infections | nausea, vomiting, diarrhoea, |
| ethanol | CNS function modifier | methanol poisoning | incoordination; cognitive impairment |
| ethinyloestradiol/levonorgestrel | suppresses pituitary gonadotrophin release, inhibiting follicular maturation and preventing ovulation. | oral contraception | venous thromboembolism |
| ethylene glycol | formation of oxalic acid | (none) | renal toxicity |
| etoposide | topoisomerase inhibitor | cancer | myelosuppression, alopecia, GI symptoms |
| felodipine | calcium channel blocker | hypertension, angina | flushing, headache, palpitation, dizziness, fatigue, gravitational oedema |
| fenoterol | beta-2 agonist | asthma | tachycardia, tremor, headache |
| fluconazole | inhibits fungal menbrane synthesis | fungal infection | GI symptoms |
| flumazenil | benzodiazepine receptor antagonist | benzodiazepine overdose | nausea |
| fluoxetine | selective serotonin reuptake inhibitor | depression | suicidal ideation, anxiety |
| fomepizole | inhibition of alcohol dehydrogenase | ethylene glycol and methanol poisoning | headache; nausea |
| frusemide | inhibits renal tubular Na re-absorption | oedema; heart failure | hypotension; hypokalaemia |
| fuller's earth | adsorption of drugs in gut | increase drug elimination and reduce drug absorption | |
| gefitinib | inhibits epidermal growth factor receptor | lung cancer | skin rash |
| gentamicin | ribosomal protein synthesis inhibitor | sepsis | nephrotoxicity; ototoxicity |
| glipizide | pancreatic beta cell stimulant of insulin release | diabetes | hypoglycaemia |
| haloperidol | dopaminergic receptor antagonist | schizophrenia | extra-pyramidal signs and symptoms |
| hydroxocobalamin | binding to cyanide | cyanide poisoning | none reported |
| ibuprofen | cyclooxygenase (COX) inhibition | inflammation | GI symptoms |
| idarucizumab F(ab) | binding to dabigatran | dabigatran overdose | none reported |
| imatinib | inhibits BCR-ALK and KIT tryosine kinases | chronic myelogenous leukaemia; gastrointestinal stroma tumours | GI symptoms |
| insulin | insulin replacement | diabetes | hypoglycaemia |
| ipecacuhana | induction of emesis | oral poisoning | not effective for poison removal |
| irinotecan | Inhibits DNA topoisomerase I and interferes with DNA replication | metastatic colorectal cancer | delayed diarrohea, neutropenia and acute cholinergic syndrome |
| ketamine | NMDA antagonist | anaesthesia | hallucinations |
| lidocaine | sodium channel blocker | anti-arrhythmic | dizziness; paraesthesia |
| loperamide | reduces gut mobility | diarrhoea | GI symptoms |
| losartan | angiotensin receptor antagonist | hypertension | hypotension, dizziness |
| MDMA ("ecstasy"); 3,4-Methylenedioxymethamphetamine | amine neurotransmitter release | (none) | hypertension; tachycardia |
| methanol | CNS function modifier | (none) | blindness |
| methotrexate | dihydrofolate reductase inhibitor | cancer | myelosuppression, GI symptoms |
| metronidazole | cysteine bearing enzyme inhibitor | bacterial infection | GI symptoms |
| morphine | mu-opioid receptor agonist | analgesia | nausea; constipation; respiratory depression |
| naloxone | opioid receptor antagonist | opioid overdose | nausea |
| neostigmine | anti-cholinesterase | reversal of muscle relaxation | salivation; diarrhoea |
| nifedipine | calcium channel blocker | hypertension | oedema, headache |
| nortriptyline | inhibit NA and 5HT reuptake | depression | sedation, anticholinergic effects |
| omeprazole | irreversible inhibition of the H+/K+-ATPase (proton pump) in the gastric parietal cells | gastro-oesophageal reflux disease; duodenal ulcer and gastric ulcer | nausea, vomiting, |
| organophosphate | anti-cholinesterase | (none) | salivation; diarrhoea |
| paclitaxel | antimicrotubule drug | cancer | myelosuppression, alopecia, GI symptoms, neurotoxicity |
| pancuronium | acetylcholine receptor blockade at neuromuscular junction | anaesthesia muscle relaxation | weakness, respiratory depression |
| paracetamol | POX-inhibitor? Cannabinoid receptor agonist? | analgesia; fever | hepatic damage |
| paraquat | superoxide anion | (none) | pulmonary fibrosis |
| PB2452 | binding to ticagrelor | ticagrelor overdose | none reported |
| penicillamine | copper, mercury chelating agent | Wilson's disease; copper, mercury poisoning | nausea |
| phenytoin | sodium channel blocker | anti-arrhythmic | ataxia; gingival hypertrophy |
| phytomenadione (vitamin K) | warfarin antagonist | bleeding due to warfarin | hypotension; neonatal jaundice |
| pralidoxime | cholinesterase re-activator | organophosphate anti-cholinesterase poisoning | nausea |
| prednisone/prednisolone | anti-inflammatory corticosteroid | asthma; rheumatoid arthritis | hypertension; glucose intolerance; psychiatric disturbance |
| probenecid | renal tubular blocking agent | gout, adjunct to beta lactam antibiotics treatment | GI symptoms |
| propofol | GABA receptors | sedation, anaesthesia | respiratry depression, hypotension |
| propranolol | beta-adrenoceptor antagonist | hypertension; angina | hypotension; bradycardia; fatigue; cold extremities |
| quetiapine | dopamine and 5HT receptor antagonist | psychosis | dry mouth, dizziness, drowsiness |
| ranitidine | histamine H2-receptor antagonist, | gastro-oesophageal reflux disease | diarrhoea, headache, dizziness |
| remifentanil | mu opioid | analgesia | respiratry depression, itch, nausea,sedation |
| rifampicin | inhibitor of bacterial RNA synthesis | tuberculosis; brucellosis | nausea, vomiting, diarrhoea, alterations of liver function, headache, dizziness, chills, fever |
| salbutamol | beta-2 agonist | asthma | tachycardia, tremor, headache |
| salicylate | COX inhibition | analgesia; fever | bleeding; gastrointestinal distress; tinnitus; acidosis |
| simvastatin | HMG CoA reductase inhibitor | prevention of cardiovascular events | gastro-intestinal disturbances, altered liver function tests, |
| spirinolactone | aldosterone receptor antagonist | hypertension | drowsiness, dizziness |
| succimer | lead, mercury, arsenic chelating agent | lead, mercury, arsenic poisoning | nausea |
| sunitinib | vascular tyrosine kinase inhibitor | cancer | bleeding, hypertension |
| tacrolimus | calcineurin inhibitor | immunosuppressant | diarrhoea; constipation |
| tamoxifen | oestrogen receptor anatagonist | breast cancer | menopausal symptons |
| terfenadine | anti-histamine | None. Withdrawn | cardiac arrhythmia |
| thalidomide | immunomodulatory and anti-inflammatory activity | multiple myeloma | vomiting, dry mouth, dyspepsia, constipation, bradycardia |
| theophylline | adenosine receptor antagonist; phosphodiesterase inhibitor | asthma; COPD | nausea; tachycardia |
| tramadol | mu receptors, spinal serotonin | analgesia | respiratory depression, nausea |
| trastuzumab | human epidermal growth factor receptor 2 binding monoclonal antibody | breast cancer | infusion reactions |
| verapamil | calcium channel blocker | hypertension | hypotension, dizziness |
| warfarin | inhibits vitamin K epoxide reductase | oral anti-coagulant | bleeding |